查看“︁3,4-二羟基-3-甲基-4-苯基-1-丁炔”︁的源代码

{{Refimprove|time=2023-06-17T03:34:09+00:00}}
{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 424810107
| IUPAC_name = 2-methyl-1-phenylbut-3-yne-1,2-diol
| image = Centalun.svg
| width = 180

<!--Clinical data-->
| tradename = 
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category = 
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = <!--             / Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL         / P       / POM / CD / Class A, B, C -->
| legal_US = <!-- OTC                   / Rx-only  / Schedule I, II, III, IV, V -->
| legal_status = Unscheduled
| routes_of_administration = 

<!--Pharmacokinetic data-->
| bioavailability = 
| protein_bound = 
| metabolism = 
| elimination_half-life = 
| excretion = 

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 2033-94-5
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 3N20VGJ39Y
| ATC_prefix = none
| ATC_suffix = 
| PubChem = 16252
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = 
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = 15421
| smiles = OC(c1ccccc1)C(C#C)(O)C
| StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI = 1S/C11H12O2/c1-3-11(2,13)10(12)9-7-5-4-6-8-9/h1,4-8,10,12-13H,2H3
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey = GQOXDWHRXDPZJK-UHFFFAOYSA-N

<!--Chemical data-->
| C=11 | H=12 | O=2 
}}
'''{{PAGENAME}}'''（{{lang-en|Centalun}}<ref name=":0">{{Cite web|title=CAS Common Chemistry|url=https://commonchemistry.cas.org/detail?cas_rn=2033-94-5|access-date=2023-05-19|website=commonchemistry.cas.org|archive-date=2023-05-19|archive-url=https://web.archive.org/web/20230519171501/https://commonchemistry.cas.org/detail?cas_rn=2033-94-5|dead-url=no}}</ref>，中文译名不详），分子式[[C11H12O2|<chem>C11H12O2</chem>]]，是一种具有催眠和镇静作用的精神药物，通过对GABAA受体<ref name=":0" />的异体激动作用，该药由林格殷格翰公司（Boehringer Ingelheim）于1962年研发<ref name=":1">{{Cite web|title=Espacenet – search results|url=https://worldwide.espacenet.com/patent/search/family/039514553/publication/BE618130Q?q=pn=BE618130|access-date=2023-05-19|website=worldwide.espacenet.com|archive-date=2023-05-19|archive-url=https://web.archive.org/web/20230519171501/https://worldwide.espacenet.com/patent/search/family/039514553/publication/BE618130Q?q=pn=BE618130|dead-url=no}}</ref>。

它以前被用于[[外科学|外科]]、[[骨科]]和[[婦科學|妇科]]等医疗程序中的镇静，但它目前已不再被临床使用。尽管有临床使用的历史，但 centalun从未被纳入CSA<ref name=":1" />，因此作为一种滥用药物仍未受到监管。<ref>{{Cite journal |date=2023-01-30 |title=Centalun |url=https://en.wikipedia.org/w/index.php?title=Centalun&oldid=1136444545 |journal=Wikipedia |language=en}}</ref>

==参考文献==
<references />
==外部链接==

[[Category:催眠药]]
[[Category:GABAA受体正向变构调节剂]]
[[Category:炔烴衍生物]]
[[Category:邻二醇]]
[[Category:苯基化合物]]